EichorEICHOR
Location: Brest Synced from ClinicalTrials.gov · August 07, 2026

Clinical studies recruiting near Brest

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Generation of an Artificial Intelligence Algorithm Based on the Analysis of Melanoma Peri-scar Dermatoheliosis, as a Pre
Phase N/A · Brest University Hospital · Nantes University Hospital · NCT05856565Use of a Freeze-dried Amniotic Membrane Post Crosslinking in Subjects With Progressive Keratoconus
Phase 3 · CHU de Brest · TBF Genie Tissulaire · NCT06450470A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Phase 3 · CHRU de Brest · Eli Lilly and Company · NCT07218380This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W
Phase 3 · Groupe Vivalto Santé - Clinique Pasteur-Lanroze · Pfizer · NCT07028853DVT Burden and the Risk of Post-thrombotic Syndrome
NA · Centre Hospitalier Universitaire de Brest · Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer · NCT06385353Program of Physical Activity, Nutrition and Supportive to Improve the Quality of Life of Breast Cancer Survivors
NA · Brest · Siel Bleu · NCT05658341Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease
Phase 2/Phase 3 · CHRU de Brest · Bristol-Myers Squibb · NCT07106762Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Phase 3 · CHRU Brest - Hopital Cavale Blanche ( Site 1304) · Merck Sharp & Dohme LLC · NCT06393374A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary Arterial Hypertension Who Have P
Phase 2 · CHRU de Brest · Pfizer · NCT07073820Emotional Intelligence and Chronic Orofacial Pain
Phase N/A · CHU DE BREST - Médecine bucco-dentaire · University Hospital, Brest · NCT07280338Study to Assess Safety, Efficacy, and Cellular Kinetics of YTB323 in Generalized Myasthenia Gravis
Phase 1/Phase 2 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT06704269Impact of Local Tissue Inflammation on Intramyocardial Conduction Pathways Post Percutaneous Valve : Evaluation by Posit
Phase 2 · CHU de Brest · University Hospital, Brest · NCT05308888French Colorectal ESD Cohort in Experts Centers
Phase N/A · CHRU de Brest · University Hospital, Limoges · NCT04592003Perioperative Dynamics of Energy Expenditure in Oesophagectomy Patients
Phase N/A · Department of Anaesthesia and Intensive Care · University Hospital, Rouen · NCT06921668Non-Invasive Ventilation Versus High-flow Nasal Oxygen in Intensive Care Units
NA · Brest University Hospital · Poitiers University Hospital · NCT05686850Identification of Genetic Variants Associated With Unexpected Infant Death Syndrome
Phase N/A · CHU Brest · Nantes University Hospital · NCT06244433Role of High-Throughput Whole Genome Sequencing for the Diagnosis and Care of Atypical Diabetes
NA · University Hospital Cavale Blanche · Institut National de la Santé Et de la Recherche Médicale, F · NCT06570278BREMISS : Brain Resilience Minor Stroke Study
NA · CHU de Brest · University Hospital, Brest · NCT06995040Diagnostic Suspicion of Primitive Syndrome Sjögren's : Brest Cohort
Phase N/A · CHRU de Brest · University Hospital, Brest · NCT03681964TTFields General Routine Clinical Care in ndGBM Patients: a French Prospective Non-Interventional Study (TIGER France)
Phase N/A · Chu Brest Hopital Morvan · NovoCure Ltd. · NCT06924099A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintena
Phase 3 · CHRU de Brest-Institut de cancérologie et d'Hématologie ( Si · Merck Sharp & Dohme LLC · NCT07216703Psychoeducation Program for Family Caregivers Coordinated by an APRN
NA · Hôpital le Vinatier · NCT07041463A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangement
Phase 1/Phase 2 · Local Institution - 4207 · Turning Point Therapeutics, Inc. · NCT03093116Study Evaluating the Analgesic Efficacy of Capsaicin 8% Patches in Chronic Coccygodynia.
Phase 3 · Brest University Hospital · Nantes University Hospital · NCT06023706Biocollection of Patients With ANCA Associated Vasculitis
NA · CHRU de Brest - Service de rhumatologie · University Hospital, Brest · NCT05364892A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Phase 2 · Hôpital Morvan · Fore Biotherapeutics · NCT05503797Visugromab in Cachexia International Trial
Phase 2/Phase 3 · CHRU de Brest - Hopital Morvan · CatalYm GmbH · NCT07112196Scapular Positioning in Standing Position Using Sonography
NA · Brest, University Hospital · University Hospital, Brest · NCT04449146A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previ
Phase 3 · Centre Hospitalier Universitaire Cavale Blanche · Pfizer · NCT07144280PFO Closure, Oral Anticoagulants or Antiplatelet Therapy After PFO-associated Stroke in Patients Aged 60 to 80 Years
Phase 3 · CHRU La Cavale Blanche · Assistance Publique - Hôpitaux de Paris · NCT05387954
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.